Keeping Up With Sleep

The sheer pace of medical research challenges clinicians who try to keep up with the burgeoning volume of literature related to obstructive sleep apnea (OSA), narcolepsy, excessive daytime sleepiness, and other sleep-related disorders. The Keeping Up With Sleep Journal Club selects key articles and shares expert commentary on them, giving learners an educational tool that helps translate emerging knowledge into improvements in clinical care.

Intended Audience
Psychiatrists, neurologists, pulmonologists, sleep specialists, and clinicians who treat patients with or at risk for sleep-related disorders

Educational Objectives
At the conclusion of this activity, participants should be better able to:

  • Characterize the impact of excessive daytime sleepiness (EDS) on patients' health, ability to function, and quality of life
  • Recognize signs and symptoms of EDS in patients with obstructive sleep apnea, narcolepsy, and other disorders related to sleep disturbances
  • Evaluate new and emerging developments in the assessment and management of EDS

FACULTY

CHAIR
Michael J. Thorpy, MB, ChB

Professor of Neurology
Albert Einstein College of Medicine
Bronx, NY

FACULTY AUTHORS
Richard K. Bogan, MD, FCCP, FAASM

Chief Medical Officer, SleepMed, Inc.
Clinical Associate Professor, Medical
  University of South Carolina
Clinical Associate Professor, University
  of South Carolina
Columbia, SC

Thomas E. Scammell, MD
Professor of Neurology
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, MA

CME REVIEWER
Imran Ahmed, MD

Program Director, Sleep Medicine
  Training Program
Associate Professor of Clinical Neurology
Associate Director, Sleep-Wake
  Disorders Center
Albert Einstein College of Medicine
Montefiore Medical Center
Bronx, NY

Victor Hatcher, PhD
Associate Dean for Continuing Medical
  Education and Research Administration
Professor, Department of Biochemistry
Professor, Department of Medicine

Provided by

In collaboration with

These activities are supported by educational grants from
Jazz Pharmaceuticals.